JNJNYSEPharmaceutical Preparations
Johnson & Johnson
$284.91-0.84 (-0.29%)Delayed price · Nov 16, 2026, 5:45 PM
Market cap
$685.87B
P/E (TTM)
42.6x
EV / EBIT
—
FCF yield
3.0%
Dividend yield
—
ROIC (10y avg.)
—
Revenue (TTM)
$99.34B
Net cash
-$27.42B
Price
Moat checklist
4/6Simple tests over the last decade. A starting point, not a verdict.
- –Average ROIC above 15%—
- ✓Stable gross margin (range under 10 pts)4.7 pp
- ✓Positive free cash flow every year10/10
- ✕Revenue growing at least 5% a year3.0%
- ✓Share count flat or shrinking-12.9%
- ✓Debt below 3 years of free cash flow2.4x
Revenue, net income and free cash flow
Margins
Returns on capital
Diluted shares outstanding
Annual change in share count: -1.5%